Literature DB >> 18804834

Molecular studies of temperature-sensitive replication of the cold-adapted B/Ann Arbor/1/66, the master donor virus for live attenuated influenza FluMist vaccines.

Zhongying Chen1, Amy Aspelund, George Kemble, Hong Jin.   

Abstract

Cold-adapted (ca) B/Ann Arbor/1/66 is the master donor virus for influenza B (MDV-B) vaccine component of live attenuated influenza FluMist vaccine. The six internal protein gene segments of MDV-B confer the characteristic cold-adapted (ca), temperature-sensitive (ts) and attenuated (att) phenotypes to the reassortant vaccine strains that contain the HA and NA RNA segments from the circulating wild type strains. Previously, we have mapped the loci in the NP, PA and M genes that determine the ca, ts and att phenotypes of MDV-B. In this report, the ts mechanism of MDV-B was described by comparing replication of MDV-B with its wild type counterpart at permissive and restricted temperatures. We showed that the PA and NP proteins of MDV-B are defective in RNA polymerase function at the restricted temperature of 37 degrees C resulting in greatly reduced viral RNA and protein synthesis. In addition, the two M1 residues, Q159 and V183 that are unique to MDV-B, contribute to reduced virus replication at temperatures greater than 33 degrees C, possibly due to the reduced M1 membrane association and its reduced virion M1 incorporation. Thus, the previously identified MDV-B loci not only reduce viral polymerase function at the restricted temperature but also affect virus assembly and release.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18804834     DOI: 10.1016/j.virol.2008.08.010

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  Essential genes from Arctic bacteria used to construct stable, temperature-sensitive bacterial vaccines.

Authors:  Barry N Duplantis; Milan Osusky; Crystal L Schmerk; Darrell R Ross; Catharine M Bosio; Francis E Nano
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

2.  Hemagglutinin Cleavability, Acid Stability, and Temperature Dependence Optimize Influenza B Virus for Replication in Human Airways.

Authors:  Manon Laporte; Annelies Stevaert; Valerie Raeymaekers; Talitha Boogaerts; Inga Nehlmeier; Winston Chiu; Mohammed Benkheil; Bart Vanaudenaerde; Stefan Pöhlmann; Lieve Naesens
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

3.  Characterization of the nucleocytoplasmic shuttle of the matrix protein of influenza B virus.

Authors:  Shuai Cao; Jingwen Jiang; Jing Li; Yan Li; Limin Yang; Shanshan Wang; Jinghua Yan; George F Gao; Wenjun Liu
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

4.  Evolutionarily conserved essential genes from arctic bacteria: a tool for vaccination.

Authors:  Mm Shanmugam; S Parasuraman
Journal:  J Young Pharm       Date:  2012-01

Review 5.  Reverse Genetics Approaches for the Development of Influenza Vaccines.

Authors:  Aitor Nogales; Luis Martínez-Sobrido
Journal:  Int J Mol Sci       Date:  2016-12-22       Impact factor: 5.923

6.  Development of an Alternative Modified Live Influenza B Virus Vaccine.

Authors:  Jefferson J S Santos; Courtney Finch; Troy Sutton; Adebimpe Obadan; Isabel Aguirre; Zhimin Wan; Diego Lopez; Ginger Geiger; Ana Silvia Gonzalez-Reiche; Lucas Ferreri; Daniel R Perez
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

7.  Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells.

Authors:  Verena Lohr; Yvonne Genzel; Ingo Jordan; Dietmar Katinger; Stefan Mahr; Volker Sandig; Udo Reichl
Journal:  BMC Biotechnol       Date:  2012-10-30       Impact factor: 2.563

8.  Principles underlying rational design of live attenuated influenza vaccines.

Authors:  Yo Han Jang; Baik-Lin Seong
Journal:  Clin Exp Vaccine Res       Date:  2012-07-31

9.  Mutations in GTP binding protein Obg of Mycoplasma synoviae vaccine strain MS-H: implications in temperature-sensitivity phenotype.

Authors:  Muhammad A Shahid; Philip F Markham; John F Markham; Marc S Marenda; Amir H Noormohammadi
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240

10.  An RNA aptamer that specifically binds to the glycosylated hemagglutinin of avian influenza virus and suppresses viral infection in cells.

Authors:  Hyun-Mi Kwon; Kwang Hyun Lee; Byung Woo Han; Mi Ra Han; Dong Ho Kim; Dong-Eun Kim
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.